<html>
<head>
<title>Utah Legislature HB0400</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>COVERAGE PARITY FOR AMINO ACID-BASED FORMULA</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2017 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Edward H. Redd</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill amends the Insurance Code.<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provides definitions;<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires a health insurer to offer at least one plan that covers amino acid-based<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;elemental formula for the diagnosis or treatment of an eosinophilic gastrointestinal<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;disorder, food protein-induced enterocolitis syndrome, severe protein allergic<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;condition, or short bowel syndrome;<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;limits coverage to formula ordered by a physician and obtained from a pharmacy;<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prohibits cost sharing for elemental formula that is less favorable to the insured than<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cost sharing for prescription drugs.<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#31a-22-623.5">31A-22-623.5</a></b>, Utah Code Annotated 1953<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>31A-22-623.5</b><a name="31a-22-623.5"></a> is enacted to read:<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31A-22-623.5.</u></b>  <b>Insurance coverage for amino acid-based formula.</b><br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Amino acid-based elemental formula" means a nutrition formula:</u><br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  made from individual nonallergenic amino acids that are broken down to enhance</u><br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>absorption and digestion; and</u><br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  designed for individuals who have a dysfunctional or shortened gastrointestinal</u><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>tract and are unable to tolerate and absorb whole foods or formulas composed of whole</u><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>proteins, fats, or carbohydrates.</u><br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Eosinophilic gastrointestinal disorder" means a disorder characterized by having</u><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>above normal amounts of eosinophils in one or more specific places anywhere in the digestive</u><br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>system.</u><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Food protein-induced enterocolitis syndrome" means a disorder characterized by</u><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>an  abnormal immune response to an ingested food, resulting in gastrointestinal inflammation.</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Health insurer" means an insurer, as defined in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=31a-22-634&session=2017GS">31A-22-634</a>(1).</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Order" means to communicate orally, in writing, or by electronic means.</u><br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(f)  "Pharmacy" means a pharmacy licensed under Title 58, Chapter 17b, Pharmacy</u><br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Practice Act.</u><br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(g)  "Physician" means an individual who is licensed under Title 58, Chapter 67, Utah</u><br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Medical Practice Act, or Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.</u><br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(h)  "Severe protein allergic conditions" includes:</u><br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  eosinophilic esophagitis;</u><br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  eosinophilic gastritis;</u><br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  eosinophilic gastroenteritis;</u><br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iv)  eosinophilic enteritis;</u><br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(v)  eosinophilic colitis;</u><br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vi)  immunoglobulin E-mediated allergies to multiple food proteins;</u><br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(vii)  nonimmunoglobulin E-mediated allergies to multiple food proteins; or</u><br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(viii)  food protein-induced enterocolitis syndrome.</u><br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  "Short bowel syndrome" means malabsorption of nutrients resulting from</u><br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>anatomical or functional loss of a significant length of the small intestine.</u><br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  A health insurer shall offer to a potential purchaser at least one health benefit plan</u><br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>that provides coverage for the use of an amino acid-based elemental formula, regardless of the</u><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>delivery method of the formula, for the diagnosis or treatment of an eosinophilic</u><br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>gastrointestinal disorder, food protein-induced enterocolitis syndrome, severe protein allergic</u><br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>condition, or short bowel syndrome.</u><br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  Coverage offered under Subsection (2) applies to an amino acid-based elemental</u><br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>formula if:</u><br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  the formula is ordered for the enrollee by a physician;</u><br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  the physician indicates in the order that the formula is medically necessary; and</u><br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  the insured obtains the formula from a pharmacy.</u><br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4)  Coverage offered under Subsection (2) may not include cost-sharing provisions,</u><br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>including deductibles, copayments, co-insurance, and out-of-pocket limits, or a durational</u><br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>limit, that are less favorable to the insured than the cost-sharing provisions and durational</u><br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>limits applied by the health benefit plan to prescription drugs.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
